From Discovery to Delivery: Implementing Precision Oncology at Scale

Precision medicine is no longer just a scientific capability, it is a systemic challenge that requires us to work at pace. We recently had the privilege of exploring this shift at the Asia-Pacific Oncology Summit (APOS) in Sydney.

The conversation has moved from what we can measure to how we actually implement these advances across health systems. 

Key takeaways from our discussions:

• Implementation over Discovery: The challenge is no longer generating genomic data, it is building the infrastructure, governance and clinical workflows to turn that data into care.
• Models for Access: Exploring managed access programs like the UK’s Cancer Drugs Fund to provide patient access while real-world evidence is gathered.
• Equity as a Standard: Ensuring comprehensive genomic profiling becomes the standard of care, with a deep focus on cultural connection and patient-centric information.
• Collaboration as the Driver: Industry, clinicians, and advocates must work in unison to move precision oncology from an “exceptional” treatment to a systemic reality.

A profound thank you to the Omico team for hosting, and to the speakers and patient advocates who grounded our conversations in reality. Your insights are a vital reminder of why coordination matters.

At InGeNA, we remain committed to representing the industry as we bridge the gap between genomic science and patient outcomes.